REQUEST A DEMO
Total
USD $0.00
Search more companies

Atomus Med Sp. z o.o. (Poland)

Main Activities: Scientific Research and Development Services
Full name: Atomus Med Sp. z o.o. Profile Updated: May 20, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Atomus Med Sp. z o.o. is an enterprise in Poland, with the main office in Zukowo. It operates in the Scientific Research and Development Services industry. The company was established on November 13, 2018. In 2023, the company reported a net sales revenue increase of 0.79%. Its total assets grew by 26.19% over the same period. In, 2023, the company’s net profit margin increased by 4.1%.

Headquarters
Ul. Batorego 21
Zukowo; Pomorskie; Postal Code: 83-330

Contact Details: Purchase the Atomus Med Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Atomus Med Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Atomus Med Sp. z o.o. report to view the information.
Incorporation Date:
November 13, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
98%
Company Performance
Financial values in the chart are available after Atomus Med Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
0.79%
Total operating revenue
0.79%
Operating profit (EBIT)
40.12%
EBITDA
40.12%
Net Profit (Loss) for the Period
40.12%
Total Assets
26.19%
Total Equity
25.45%
Operating Profit Margin (ROS)
4.5%
Net Profit Margin
4.1%
Return on Equity (ROE)
2.12%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?